Rinvoq (Upadacitinib)

Rinvoq (upadacitinib) is a Disease Modifying Anti-Rheumatic Drug (DMARD) that's currently used to treat rheumatoid arthritis with and without methotrexate. Its effectiveness is currently being studied for other types of arthritis.

Rinvoq works by suppressing the immune system. It belongs to a class of medications known as Janus Kinase (JAK) inhibitors.

Taking Rinvoq

Rinvoq is one of the few therapies for arthritis that is available as an oral tablet. The standard dose is 15 mg taken once every day.

Rinvoq does not work right away. It can take about 2 to 8 weeks before patients start feeling better, and it can take 3 to 6 months to feel the maximum effect of this medication. If the dose is changed, it can take 2-8 weeks to feel the effects.

Important Tests and Risks

Science

Safety

Resource(s)

Rinvoq Quick Reference Guide